Q BioMed Inc. Announces Development Partnership with Sphaera Pharma
Q BioMed Inc., a biotechnology acceleration company, announced today a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder.
View full press release